By Fineline Cube 
China’s Ministry of Industry and Information Technology, Ministry of Commerce, National Health Commission (NHC), and four other ministries have jointly released the “Implementation Plan for the Digital Transformation of the Pharmaceutical Industry (2025-2030)”. The Plan outlines a roadmap for the pharmaceutical sector to achieve significant progress in digital-intelligent transformation by 2027 and full coverage of digital-intelligent transformation in large-scale pharmaceutical enterprises by 2030.
Key Objectives by 2027
The Plan sets forth several key objectives to be achieved by 2027:
- Digital-Intelligent Infrastructure Development: Achieve breakthroughs in critical digital-intelligent technologies for pharmaceutical manufacturing, formulate/revise over 30 technical standards for pharmaceutical industrial digitalization, and R&D/ deploy over 100 high-performance products such as intelligent pharmaceutical manufacturing equipment, testing instruments, and industrial software.
- Digital-Intelligent Transformation Scaling: Create over 100 exemplary application scenarios for digital-intelligent technologies, establish over 100 digital-intelligent pharmaceutical/medical device factories, develop over 50 pioneering exemplary enterprises in digital-intelligent transformation, and construct 5 exemplary pharmaceutical digital-intelligent transformation industrial parks.
- Support Ecosystem Development: Set up a national pharmaceutical industrial digital-intelligent transformation promotion center with regional branches, deploy over 10 pharmaceutical-specific large-model innovation platforms and digital technology validation/pilot platforms, and cultivate over 30 specialized service providers for pharmaceutical industrial digital-intelligent transformation.
Vision for 2030
By 2030, all large-scale pharmaceutical enterprises are expected to achieve full digital-intelligent transformation coverage. This will be marked by significantly enhanced integrated innovation capabilities in digital technologies, a further optimized industry-wide data ecosystem, and a fully institutionalized digital-intelligent transformation framework.
Key Tasks Proposed in the Plan
The “Plan” proposes several key tasks, including:
- R&D of intelligent technology and products in the pharmaceutical industry
- Creation of typical intelligent application scenarios
- Construction of intelligent service systems
These tasks encompass the construction of pharmaceutical quality management standard systems, intelligent pharmaceutical equipment and quality monitoring, intelligent pharmaceutical circulation traceability, and CXO intelligent collaboration, among others.-Fineline Info & Tech